Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) — Commack, New York

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is a clinical research site located in Commack, New York, United States 11725.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Breast Cancer, Invasive Breast Cancer, Smoking.

Sponsors: Memorial Sloan Kettering Cancer Center.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)?

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) conducted?

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) has 5 clinical trials on record, with 4 currently active. Their work covers Breast Cancer, Invasive Breast Cancer, Smoking.

Is Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) accredited by Crixeo Health?

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.